Proteomic applications in blood transfusion: working the jigsaw puzzle

被引:8
作者
Devine, D. V. [1 ]
Schubert, P.
机构
[1] Univ British Columbia, Canadian Blood Serv, Ctr Blood Res, Vancouver, BC V6T 1Z3, Canada
关键词
blood components; blood plasma; blood platelets; proteomics; red blood cells; transfusion medicine; FRESH-FROZEN PLASMA; MASS-SPECTROMETRY; PROTEIN IDENTIFICATION; 2-DIMENSIONAL ELECTROPHORESIS; PLATELET STORAGE; DYNAMIC-RANGE; BIOMARKERS; MEMBRANE; QUALITY; THERAPEUTICS;
D O I
10.1111/j.1423-0410.2010.01433.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The application of proteomic technologies to transfusion medicine has opened new avenues to our understanding of the products we prepare for patients and the processes that impact the quality of those products. The development of the field of proteomics has paralleled that of transfusion medicine with over a century of key scientific accomplishments required to bring us to our modern systems. We review the technology of proteomics and its application to transfusion medicine with specific reference to the analysis of blood products, both fractionated and fresh. Although the use of proteomic tools to address transfusion medicine questions is really just beginning, it is clear that this method of analysis provides different insights into unaddressed issues in the area of blood product research. Proteomics also offers the promise of improving our approach to the control of blood product quality and even the assessment of blood donors, but these are efforts for the near future.
引用
收藏
页码:84 / 91
页数:8
相关论文
共 74 条
[11]   The proteome of red cell membranes and vesicles during storage in blood bank conditions [J].
Bosman, Giel J. C. G. M. ;
Lasonder, Edwin ;
Luten, Marleen ;
Roerdinkholder-Stoelwinder, Bregt ;
Novotny, Vera M. J. ;
Bos, Harry ;
De Grip, Willem J. .
TRANSFUSION, 2008, 48 (05) :827-835
[12]   Changes in band 3 structure as determinants of erythrocyte integrity during storage and survival after transfusion [J].
Bosman, Giel J. C. G. M. ;
Stappers, Mark ;
Novotny, Vera M. J. .
BLOOD TRANSFUSION, 2010, 8 :S48-S52
[13]   Proteomics as a tool for assessment of therapeutics in transfusion medicine:: evaluation of prothrombin complex concentrates [J].
Brigulla, M ;
Thiele, T ;
Scharf, C ;
Breitner-Ruddock, S ;
Venz, S ;
Völker, U ;
Greinacher, A .
TRANSFUSION, 2006, 46 (03) :377-385
[14]   A central resource for platelet proteomics [J].
Cagney, Gerard ;
McRedmond, James .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (07) :1214-1215
[15]   Serum protein profiling by solid phase extraction and mass spectrometry: A future diagnostics tool? [J].
Callesen, Anne K. ;
Madsen, Jonna S. ;
Vach, Werner ;
Kruse, Torben A. ;
Mogensen, Ole ;
Jensen, Ole N. .
PROTEOMICS, 2009, 9 (06) :1428-1441
[16]   Decoding signalling networks by mass spectrometry-based proteomics [J].
Choudhary, Chunaram ;
Mann, Matthias .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2010, 11 (06) :427-439
[17]   Use of proteomics for validation of the isolation process of clotting factor IX from human plasma [J].
Clifton, James ;
Huang, Feilei ;
Gaso-Sokac, Dajana ;
Brilliant, Kate ;
Hixson, Douglas ;
Josic, Djuro .
JOURNAL OF PROTEOMICS, 2010, 73 (03) :678-688
[18]   Proteomic characterization of plasma-derived clotting factor VIII-von Willebrand factor concentrates [J].
Clifton, James G. ;
Huang, Feilei ;
Kovac, Spomenka ;
Yang, Xinli ;
Hixson, Douglas C. ;
Josic, Djuro .
ELECTROPHORESIS, 2009, 30 (20) :3636-3646
[19]  
Corthals GL, 2000, ELECTROPHORESIS, V21, P1104, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1104::AID-ELPS1104>3.0.CO
[20]  
2-C